Global Stem Cells Group subsidiary Adimarket launches new exosome cell therapy product for regenerative medicine practitioners

Industry: Healthcare

Global Stem Cells Group subsidiary Adimarket announces the launch of a new exosome acellular therapy product for regenerative medicine practitioners.

Miami Lake (PRUnderground) September 19th, 2018

Adimarket, a subsidiary of Global Stem Cells Group, Inc. announces the launch of a new exosome acellular therapy product that my be used as an acellular alternative to stem cells  for treating degenerative illnesses, sports injuries and orthopedic injuries.

Researchers have found that exosomes, nano-sized vesicles released by all cell types including stem cells, play an important role in cell-to-cell communication.

They contain proteins, RNA, cytokines and growth factors to help combat disease. Exosomes derived from adult human bone marrow and tissue-specific mesenchymal stem cells (MSCs) display multiple therapeutic functions and offer a method to provide cell-free regenerative medicine therapies.

Clinical Applications for stem cell-derived exosomes include treatments for orthopedic injuries, sports injuries, and degenerative illnesses such as bone fractures, tendon injuries,  rheumatoid arthritis (RA), bone fractures and more.

There have been numerous therapeutic discoveries regarding stem cell-derived exosomes  in recent years. For example, researchers have found that exosomes released from human induced pluripotent stem cell-derived mesenchymal stem cells repair tissue and enhance cutaneous wound healing due to the exosomes promotion of collagen synthesis and angiogenesis, which acts to reduce scar widths and promote collagen maturity.

Thanks to the unique ability of stem cell-derived exosomes,  cell-free regenerative medicine products are quickly evolving.

To learn more about Adimarket’s new exosome product, visit theAdimarket website, email bnovas@stemcellsgroup.com, or call 305-560-5337.

About Adimarket:

Adimarket, Inc., a division of the Global Stem Cells Group, is a cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals.

Adimarket was founded to provide physicians and other health care professionals the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact the practice of stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting edge treatments.

Adimarket’s experienced customer service representatives provide valuable guidance and advice regarding products relevant to individual practices.

About Global Stem Cells Group

Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.

Print Friendly, PDF & Email

Become a Fan

Press Contact

Name
Benito Novas
Phone
+1 305 560 5337
Email
Contact Us
Website
https://www.adimarket.net/

Image Gallery

Video